1Hidalgo I J,Raub TJ,Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability[J].Gastroenterology,1989.736-749. 被引量：1
2Chong S,Dondo SA,Soucek KM. In vitro permeability through Caco-2 cells is not quantitatively predictive of in vivo absorption for peptide-like drugs absorbed via the dipeptide transport system[J].Pharmaceutical Research,1996.120-123. 被引量：1
3Zeynep S,Teksin,Paul R. Comparison of Drug Permeabilities and BCS Classification:Three Lipid-Component PAMPA System Method versus Caco-2 Monolayers[J].The AAPS Journal,2010,(02):238-241. 被引量：1
4Kansy M,Senner FK. Physicochemical high throughput screening:parallel artificial membrane permeability assay in the description of passive absorption processes[J].Medicinal Chemistry,1998.1007-1010. 被引量：1
5Wohnsland F,Failer B. High-throughput permeability pH profile and high-throughput alkane/water logP with artificial membranes[J].Medicinal Chemistry,2001.923-930. 被引量：1
6Avdeef A,Strafford M,Block E. Drug absorption in vitro model: filter-immobilized artificial membranes. 2.Studies of the permeability properties of lactones in Piper methysticum Forst[J].European Journal of Pharmaceutical Sciences,2001.271-280. 被引量：1
7Avdeef A. Absorption and Drug Development[M].WileyInter science,New York,2003.117. 被引量：1
8Huque FT,Box K,Platts JA. Permeability through DOPC/dodecane membranes:measurement and LFER modeling[J].European Journal of Pharmaceutical Sciences,2004.223-232. 被引量：1
9Sugano K,Hamada H,Machida M. Optimized conditions of bio-mimetic artificial membrane permeation assay[J].International Journal of Pharmaceutics,2001.181-188. 被引量：1
10Di L,Kerns EH,Fan K. High throughput artificial membrane permeability assay for blood-brain barrier[J].European Journal of Medicinal Chemistry,2003,(3):223-232.doi:10.1016/S0223-5234(03)00012-6. 被引量：1
